Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Carotid Stenting: Flow Reversal Technique: 2-Dimensional Operative Video
Domingo, Ricardo A. , Ravindran, Krishnan , Tawk, Rabih G. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , Tawk, Rabih G , Schirmer, Clemens M , Domingo, Ricardo A , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Aziz‐Sultan, Mohammad Ali , Thomas, Ajith J , White, Jonathan Samuel

Mayo Clinic

Operative Neurosurgery | April 30, 2021 | Volume: 21 | Issue: 2 | Pages: E111-E112

10.1093/ons/opab119 | PMID 33929024 Get It

Abstract Management options for carotid stenosis include medical management, carotid endarterectomy, carotid stenting with distal filter protection, or stenting with either flow arrest or flow reversal techniques. 1 Flow reversal with transcarotid artery revascularization (TCAR) technique represents a hybrid approach with surgical access to the common carotid for endovascular placement of a stent in the internal carotid artery. This direct access to the carotid artery avoids navigating the challenging anatomy of the aortic arch with endovascular devices. 2 Compared to transfemoral stenting, TCAR possesses lower risk of transient ischemic attack and stroke, and compared to carotid endarterectomy, there is less risk of cranial neuropathy. 3,4 We present the case of an 87-yr-old man with recurrent severe stenosis (85%) of the right internal carotid artery. The patient had a remote history of bilateral endarterectomies for asymptomatic stenosis and was found with recurrence and progression of right internal carotid artery stenosis. Options were discussed and decision was made to proceed with TCAR after he consented for the procedure. The patient tolerated the procedure well with satisfactory revascularization. Exam remained unremarkable prior to discharge on postoperative day 1 and during follow-up at 1 mo. Patient consented to the publication of their image.
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration
Ravi, Praful , Pond, Gregory R. , Diamantopoulos, Leonidas Nikolaos , Su, Christopher , Alva, Ajjai , Skelton, William Paul , Gupta, Sumati , Olson, Kathleen M., Grunewald, Camilla M. , Mossanen, Matthew , Curran, Catherine , Grivas, Petros , Sonpavde, Guru , Singh, Parminder , Skelton, William P , Bandini, Marco , Necchi, Andrea , Mossanen, Matthew , Su, Christopher , Pond, Gregory Russell , Diamantopoulos, Leonidas N , Singh, Parminder , Jain, Rohit , Tward, Jonathan D. , Singh, Parminder Pal , Niegisch, Günter , Lee, Jae‐Lyun , Gallina, Andrea , Necchi, Andrea , McGregor, Bradley A.

Mayo Clinic

BJU International | April 28, 2021 | Volume: 128 | Issue: 5 | Pages: 607-614

10.1111/bju.15434 | PMID 33909949 Get It

Objectives To evaluate outcomes of patients achieving a post‐treatment pathological stage of <ypT2N0 at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) for muscle‐invasive bladder cancer (MIBC) to identify an optimal definition of pathological response. Patients and Methods Patients from 10 international centres who underwent NAC for cT2–4aN0–1 MIBC and achieved <ypT2N0 disease at RC were included. The primary outcome was time to recurrence, either local or distant. Kaplan–Meier and Cox proportional hazards regression were used to evaluate associations between clinicopathological variables and outcomes. Results A total of 625 patients were included. The median age was 66 years and 80% were male. Gemcitabine and cisplatin (GC, 56%) and methotrexate, vinblastine, doxorubicin and cisplatin (MVAC)/dose‐dense (dd)MVAC (32%) were the most common NAC regimens. ypT0, pure ypTis, ypTa ±ypTis and ypT1 ± ypTis were attained in 58.1%, 20.0%, 7.6% and 14.2% of patients, respectively. The cumulative incidence of recurrence at 5 years was 9%, 16%, 29% and 30%, respectively. Pathological stage was prognostic for recurrence, with ypTa ± Tis (hazard ratio [HR] 3.20, 95% confidence interval [CI] 1.40–7.30) and ypT1 ± Tis disease (HR 4.03, 95% CI 2.13–7.63) associated with a significantly higher recurrence risk. Pure ypTis (HR 1.66, 95% CI 0.82–3.38) and the type of NAC regimen (ddMVAC: HR 1.59, 95% CI 0.55–4.56; MVAC: HR 1.18, 9%% CI 0.25–5.54; reference: GC) were not associated with recurrence. Conclusion We propose that optimal pathological response after NAC be defined as attainment of ypT0N0/ypTisN0 at RC. Patients with ypTaN0 or ypT1N0 disease (with or without Tis) at RC displayed a significantly higher risk of recurrence and may be candidates for trials investigating adjuvant therapy.
Intracranial Access: Dural Venous Sinus Stenting: 2-Dimensional Operative Video
Domingo, Ricardo A. , Ravindran, Krishnan , Kulakova, Katya, Tawk, Rabih G. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , White, Jonathan, Tawk, Rabih G , Schirmer, Clemens M , Domingo, Ricardo A , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Thomas, Ajith J , White, Jonathan A.

Mayo Clinic

Operative Neurosurgery | April 23, 2021 | Volume: 21 | Issue: 2 | Pages: E113-E114

10.1093/ons/opab120 | PMID 33891009 Get It

Abstract Cerebral venous sinus stenting has gained popularity in recent years as a safe and efficacious treatment of selected patients with idiopathic intracranial hypertension (IIH) and focal venous sinus stenosis.1–3 - 3 The main goal of treatment is to prevent visual loss, and often patients report resolution of headache and visual symptoms within 21 mo of mean follow-up.4–8 - 8 We present the case of a 57-yr-old woman with medically refractory IIH, bilateral sinus stenosis, and a mass lesion causing stenosis on the left. Venous angiogram with pressure monitoring was completed with the patient awake, which showed a significant pressure gradient on the right (19 mm Hg) and borderline gradient on the left (8 mm Hg). Options were reviewed and decision was made to proceed with the treatment of the right-sided stenosis with stenting and continue with the observation of the lesion on the left to prevent further visual deterioration. The patient consented for the procedure, and she tolerated the procedure well. Neurological exam remained at baseline, and she was discharged home on post-operative day #1. At 2 mo’s follow-up, the patient reported improvement in headaches and remained intact neurologically.
Prophylactic Drainage after Appendectomy for Perforated Appendicitis in Adults: A Post Hoc Analysis of an EAST Multi-Center Study
Qian, Sinong , Vasileiou, Georgia , Pust, Gerd Daniel , Zakrison, Tanya L. , Rattan, Rishi , Zielinski, Martin D. , Ray-Zack, Mohamed D. , Group, on behalf of the EAST Appendicitis Study, Alouidor, Reginald, Hing, Kailyn Kwong, Sharp, Victoria , Serena, Thomas , Kasotakis, George , Perez, Sean, Allmond, Stacie L., Long, Bruce, Barth, Nadine, Roman, Janika San, Lawless, Ryan A. , Cralley, Alexis , Gelbard, Rondi B. , Szczepanski, Crystal, Eyer, Steven D., Proulx, Kaitlyn, Wild, Jeffrey, Young, Katelyn , Teicher, Erik J. , Lita, Elena, Morris, David S. , Juarez, Laura, Catalano, Richard D., Turay, David, Roberts, Jennifer C., Kaafarani, Haytham M.A., Eid, Ahmed , Kanaan, Tala , Portillo, Victor, Collom, Morgan, Eddine, Savo Bou Zein , Tabrizi, Maryam B. , Elsharkawy, Ahmed Elsayed Mohammed , Yeh, D. Dante, Evans, David , Vázquez, Daniel , Saxe, Jonathan M. , Jacobson, Lewis E. , Behrens, Brandon, Joseph, Bellal , Mull, Jennifer, Pasley, Jason, O’Meara, Lindsay , Gök, Ali , To, Jocelyn, Bradley, Matthew J. , Zielinski, Martin, Zeeshan, Muhammad , Namias, Nicholas , Yeh, D. Dante , Group, on behalf of the EAST Appendicitis Study, Morris, David, Cullinane, Daniel C. , Roberts, Jennifer C., Dodgion, Christopher M. , Yeh, D. Dante, Vazquez, Daniel E., Schreiber, Martin J. , Nahmias, Jeffry T. , Sun, Beatrice J. , Crandall, Marie , Rodríguez, Carlos

Mayo Clinic

Surgical Infections | April 20, 2021 | Volume: 22 | Issue: 8 | Pages: 780-786

10.1089/sur.2019.258 | PMID 33877912 Get It

An unusual case of aggressive malignant spread of epithelioid hemangioendothelioma
Hickman, Ashley , Roden, Anja C. , Hendrickson, Andrea E. Wahner , Hickman, Ashley D, Bezerra, Evandro D. , Barlow, Jonathan D. , Wahner Hendrickson, Andrea E , Houdek, Matthew T. , Robinson, Steven I.

Mayo Clinic

Rare Tumors | April 20, 2021 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/20363613211010858 | PMID 33959241 Get It

Epithelioid hemangioendothelioma (EHE) is a rare vascular neoplasm which typically originates from liver, lung, or bone. Due to the low incidence of disease, the most effective treatment is not easily studied and much of the information known about EHE has been learned through case reports and case series. In this case, we will present an uncommon form of primary soft tissue EHE with local recurrence, bone metastasis, and lymphangitic spread to the lungs leading to respiratory failure. Imaging of the chest was atypical for EHE with intraseptal thickening and hilar lymphadenopathy. Respiratory failure was progressive despite aggressive multimodal treatment. This case highlights an unusually aggressive recurrence and metastasis of primary soft tissue EHE with atypical pulmonary imaging findings.
Developing a Diagnostic CT Scoring System for Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency Patients
Hartono, Stella , Cox, Christian W. , Lindell, Rebecca M. , Joshi, Avni Y. , Chung, Jonathan Hero

Mayo Clinic

No container title available | April 19, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-406317/v1 Get It

Abstract PurposeTo determine the utility of GLILD CT scoring system for assessment of GLILD in patients with CVID to avoid the need for lung biopsy. MethodsThe CT scoring system was developed as a consensus based on review of literature. Two radiologists, blinded to patient clinical information, retrospectively scored CT scans of selected patients with histopathologic diagnosis of GLILD. Discrepancies were settled by a third radiologist. Inter-observer reproducibility was calculated with intra-class correlation coefficients. ResultsWe identified 25 CVID patients with histologically confirmed GLILD (12 male, 13 female). The median age was 38 years (range 12 – 72 years). Inter-observer reproducibility was 0.76 (95% CI 0.53 – 0.89). Splenomegaly/splenectomy and basilar predominant perilymphatic nodules greater than or equal to 4mm have good interobserver agreement in our CT scoring system. Discrepancy between observers occurred most often in differentiating intermediate versus high confidence diagnosis of GLILD as opposed to differentiating between low versus intermediate confidence. ConclusionGLILD CT scoring system of pulmonary disease in CVID patients can stratify patients into categories that may assist in avoiding lung biopsy for diagnosis in a subset of patients.
Endovascular Treatment of Basilar Bifurcation Aneurysms With PulseRider-Assisted Coiling: 2-Dimensional Operative Video
Sattur, Mithun G. , Kasab, Sami Al , Spiotta, Alejandro M , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond, Veznedaroglu, Erol, Welch, Babu G. , White, Jonathan, Spiotta, Alejandro M , Schirmer, Clemens M , Porto, Guilherme , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan A.

Mayo Clinic

Operative Neurosurgery | April 17, 2021 | Volume: 21 | Issue: 2 | Pages: E109-E110

10.1093/ons/opab102 | PMID 33861344 Get It

Abstract Wide-necked bifurcation aneurysms pose technical and anatomical challenges to endovascular treatment, which make the simpler assisted (balloon or single stent) coiling techniques less effective. 1 Consequently, unique endovascular solutions to treat such aneurysms have been devised. 2,3 One such device is PulseRider (Cerenovus, New Brunswick, New Jersey), which is designed to provide neck support for a coil mass while protecting the bifurcation. 3 The device comprises a body or stem that is deployed in the parent artery and a saddle component that sits at the aneurysm neck to keep the coil mass away from the bifurcation. There are several technical nuances involved in successful use of the device during positioning, deployment, and detachment. 3 We present a surgical video detailing the steps of PulseRider-assisted coiling of unruptured basilar bifurcation (or basilar apex) aneurysms. The first case highlights index treatment at diagnosis and the second showcases treatment of a recurrent basilar apex aneurysm. Both patients provided informed consent to the procedure. We also briefly discuss the rationale for treating basilar apex aneurysms. 4,5
Middle Cerebral Artery Thrombectomy: Clinical Findings and Technical Pearls: 2-Dimensional Operative Video
Rangwala, Shivani D. , Selvan, Pradeep, Tenser, Matthew, Mack, William J. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , Schirmer, Clemens M , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan Samuel

Mayo Clinic

Operative Neurosurgery | April 17, 2021 | Volume: 21 | Issue: 2 | Pages: E107-E108

10.1093/ons/opab101 | PMID 33861327 Get It

Abstract Mechanical thrombectomy as a treatment for large vessel occlusion to achieve rapid revascularization is supported in the literature. 1-3 The presenting symptoms will localize to functions of the ischemic area. The middle cerebral artery (MCA) supplies areas of the frontal, temporal, and parietal cortices, as well as the basal ganglia. Occlusion of the MCA will present with contralateral hemiplegia, sensory loss, and, if the dominant hemisphere is involved, language deficits. We present a right-hand-dominant 79-yr-old female with right MCA syndrome—her last known well time was 1.5 h prior to presentation. Her NIH (National Institutes of Health) Stroke Scale was 16, most notable for left hemiplegia. Although the patient presented early in the clinical time course, as part of our institution protocol, a computed tomography (CT) head, CT perfusion, and CT angiogram (CTA) were performed. CT head did not demonstrate acute hemorrhage, so she received intravenous tissue plasminogen activator. CTA demonstrated a right MCA occlusion and CT perfusion suggested a large area of salvageable tissue, so she was taken to the angiography suite for mechanical thrombectomy. Angiography of the right internal carotid artery (ICA) showed MCA occlusion (insular segment). A thrombectomy device was deployed over the area of occlusion and allowed to engage for 5 min. An aspiration catheter was advanced over the stentriever up against the clot. The stentriever device was withdrawn under continuous aspiration and follow-up angiography showed complete reperfusion. The patient demonstrated improvement and was eventually discharged to an inpatient rehabilitation center. Patient provided consent for photography per university protocol. Institutional review board (IRB) approval was not needed for the single-patient data included in this report.
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up
Heuer, Dale K. , Higginbotham, Eve J. , Parrish, Richard , Khanna, Cheryl L. , Brandt, James D. , Soltau, Joern B., Keltner, John L., Huecker, Julia B., Wilson, Bradley , Gordon, Mae O. , Group, Ocular Hypertension Study, Gedee, Steven J., Esquiabro, Maria, Fabrizio, Matthew J., Patorgis, Charles J., Long, Teresa A., McManus, Paul E., Washington, Chantura, Chang, Peter , Orengo-Nania, Silvia, Leger, April, Kinast, Robert M. , Jones, Emily P., Goldman, Casie, Beck, Allen D. , Costarides, Anastasios P., Leef, Donna, Imami, Nauman R., Darnley-Fisch, Deborah , Crandall, David, Gutkowski, Melanie, Hall, Julianne, Fantin, Aldo, Wells, Judy, Jampel, Henry , Quigley, Harry A., Miller, Rhonda, Kalarn, Sachin , Coleman, Anne L. , Young, Jonathan W., Peterson, Christine A., Giaconi, JoAnn A. , Law, Simon K., Duarte, Pamela B., Wood, Sarah Dougherty , Moroi, Sayoki, Gilbert, Jesse L., Shukairy, Aman, Juzych, Mark S. , Milanovic, Cheryl, O'Grady, John M., Conett, Linda A. Van, Mohay-Ambrus, Judith, Bottorff, Michelle, Bennett, Jeffrey R., Sultze, Jane L., Patel, Dharmendra, Cobb, Steven H., Bhattacharjee, Pompa, Cioffi, George A., Blumberg, Dana M., Moraes, Carlos Gustavo De , Atakulova, Marzhan, Weber, Paul A., Sawchyn, Andrea K., Williams, Demarcus, Bennett, George, Bennett, Lindsay C., Miller-Ellis, Eydie , Sankar, Prithvi S. , Grand-Drossner, Sheri, Piltz‐Seymour, Jody R., Niemczyk, Jane L., Brandt, James D., Lim, Michelle, Balasubramaniam, Saranya C., Baik, Annie K., Arnold, Marisa S., Slight, J. Rigby, Ou, Yvonne , Lamping, Kathleen A., Vitelli, Cheryl L., Ashburn, Frank S., Hardney, Karen S., Schwartz, Arthur L., Weiss, Howard S., Clark, Clete, Bhorade, Anjali M., Lind, John T., Adcock, Eve, Plumb, Kim, Leming, Laura, Dillon, B A, Palmberg, Paul, Hodapp, Elizabeth, Varner, Elizabeth A., Savatovsky, Eleonore , Vandenbroucke, Ruth, Dirkes, Keri , Vega, Suzanne , Hunsicker, Maria, Proudfoot, J. , Dunn, D, Everett, Donald F., Gutowski, Melanie, Fischbach, Ellen, Clark, Karen A., Morris, Patricia A., Quinn, Melanie, Pistorius, Sam, Haertter, Leonard W., Kass, Michael A. , Johnson, Chris A. , Liu, Lei , Miller, J. Philip , Quigley, Harry A. , Group, Ocular Hypertension Study, Patorgis, Charles J., Washington, Chantura, Mansberger, Steven L. , Wells, Judy, Quigley, Harry A., Saeedi, Osamah J. , Hughes, Bret A. , Liebmann, Jeffrey M. , Al‐Aswad, Lama A. , Brandt, James D., Lim, Michelle C., Weinreb, Robert Neal , Smith, Mike A., Feuer, William J. , Zangwill, Linda M. , Morris, Patricia A.

Mayo Clinic

JAMA Ophthalmology | April 17, 2021 | Volume: 139 | Issue: 5 | Pages: 558

10.1001/jamaophthalmol.2021.0341 | PMID 33856434 Get It

Patient-reported outcome improvements at 24-month follow-up after fusion added to decompression for grade I degenerative lumbar spondylolisthesis: a multicenter study using the Quality Outcomes Database
Bisson, Erica F. , Bydon, Mohamad , Alvi, Mohammed Ali , Glassman, Steven D. , Foley, Kevin T. , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Yew, Andrew, Haid, Regis W., Chan, Andrew K. , Mummaneni, Praveen V. , Alvi, Mohammed A, Alvi, Mohammed Ali , Guan, Jian , Goyal, Anshit

Mayo Clinic

Journal of Neurosurgery: Spine | April 16, 2021 | Volume: 35 | Issue: 1 | Pages: 42-51

10.3171/2020.9.spine201082 | PMID 33862593 Get It

OBJECTIVE The ideal surgical management of grade I lumbar spondylolisthesis has not been determined despite extensive prior investigations. In this cohort study, the authors used data from the large, multicenter, prospectively collected Quality Outcomes Database to bridge the gap between the findings in previous randomized trials and those in a more heterogeneous population treated in a typical practice. The objective was to assess the difference in patient-reported outcomes among patients undergoing decompression alone or decompression plus fusion. METHODS The primary outcome measure was change in 24-month Oswestry Disability Index (ODI) scores. The minimal clinically important difference (MCID) in ODI score change and 30% change in ODI score at 24 months were also evaluated. After adjusting for patient-specific and clinical factors, multivariable linear and logistic regressions were employed to evaluate the impact of fusion on outcomes. To account for differences in age, sex, body mass index, and baseline listhesis, a sensitivity analysis was performed using propensity score analysis to match patients undergoing decompression only with those undergoing decompression and fusion. RESULTS In total, 608 patients who had grade I lumbar spondylolisthesis were identified (85.5% with at least 24 months of follow-up); 140 (23.0%) underwent decompression alone and 468 (77.0%) underwent decompression and fusion. The 24-month change in ODI score was significantly greater in the fusion plus decompression group than in the decompression-only group (−25.8 ± 20.0 vs −15.2 ± 19.8, p < 0.001). Fusion remained independently associated with 24-month ODI score change (B = −7.05, 95% CI −10.70 to −3.39, p ≤ 0.001) in multivariable regression analysis, as well as with achieving the MCID for the ODI score (OR 1.767, 95% CI 1.058–2.944, p = 0.029) and 30% change in ODI score (OR 2.371, 95% CI 1.286–4.371, p = 0.005). Propensity score analysis resulted in 94 patients in the decompression-only group matched 1 to 1 with 94 patients in the fusion group. The addition of fusion to decompression remained a significant predictor of 24-month change in the ODI score (B = 2.796, 95% CI 2.228–13.275, p = 0.006) and of achieving the 24-month MCID ODI score (OR 2.898, 95% CI 1.214–6.914, p = 0.016) and 24-month 30% change in ODI score (OR 2.300, 95% CI 1.014–5.216, p = 0.046). CONCLUSIONS These results suggest that decompression plus fusion in patients with grade I lumbar spondylolisthesis may be associated with superior outcomes at 24 months compared with decompression alone, both in reduction of disability and in achieving clinically meaningful improvement. Longer-term follow-up is warranted to assess whether this effect is sustained.